Lower body mass index is associated with the achievement of target LDL in patients using PCSK9 inhibitors in Taiwan

Table 5 The univariate and multivariable logistic regression of LDL target achiever in patients receiving PCSK9 inhibitors post 12 weeks

	Univariate			Multivariable
	OR	95% CI	P	OR	95% CI	P
Age	1.011	(0.990–1.033)	0.298	1.009	(0.981–1.039)	0.517
Sex (vs. female)	1.055	(0.575–1.933)	0.863	0.779	(0.334–1.820)	0.564
Body mass index	0.904	(0.833–0.982)	0.016	0.899	(0.821–0.984)	0.021
History of myocardial infarction	2.040	(1.123–3.705)	0.019	2.230	(0.996–4.996)	0.051
Anti-platelet drug use	2.615	(1.175–5.820)	0.019	2.864	(0.865–9.486)	0.085

ISSN: 2047-783X